Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P450 2C9 für Pharmakokinetik und Wirkungen der nichtsteroidalen Antiphlogistika Diclofenac und Ibuprofen

Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P450 2C9 für Pharmakokinetik und Wirkungen der nichtsteroidalen Antiphlogistika Diclofenac und Ibuprofen

Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P450 2C9 für Pharmakokinetik und Wirkungen von Diclofenac und Ibuprofen Es wird angenommen, dass Cytochrom-P450 2C9 die 4’-Hydroxylierung des Nichtsteroidalen Antiphlogistikums Diclofenac und die Hydroxylierung von S-Ibuprofen beim Mensche...

Full description

Bibliographic Details
Main Author:	Freytag, Georg Tobias Heinrich
Other Authors:	Roots, I.
Format:	Doctoral Thesis
Language:	German
Published:	Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité 2005
Subjects:	Cytochrom P450 Cyp 2C9 Diclofenac Ibuprofen Cox-1 Cox-2 610 Medizin 33 Medizin VS 8767 XI 1804 XI 1819 VX 8557 ddc:610
Online Access:	http://edoc.hu-berlin.de/18452/15888 http://nbn-resolving.de/urn:nbn:de:kobv:11-10040836 http://nbn-resolving.de/urn:nbn:de:kobv:11-10043990 http://nbn-resolving.de/urn:nbn:de:kobv:11-10044004 http://dx.doi.org/10.18452/15236

Similar Items

Gastroskopische Befunde und Blutungshäufigkeit unter der Therapie mit herkömmlichen nichtsteroidalen Antirheumatika, selektiven COX-2 Inhibitoren und low dose Acetylsalicylsäure
by: Neitzel, Regina
Published: (2006)

Pharmacokinetics of diclofenac in healthy controls with wild-type phenotype for CYP2C9 shows metabolism variability
by: M. Martín-De Saro, et al.
Published: (2017-04-01)

Assessment of the impact of PTGS1, PTGS2 and CYP2C9 polymorphisms on pain, effectiveness and safety of NSAID therapies
by: Miriam Dawidowicz, et al.
Published: (2020-11-01)

Bedeutung von Cytochrom-P450-Polymorphismen für Verlauf, Erfolg und Nebenwirkungen der Therapie mit Antidepressiva
by: Lorberg, Caroline
Published: (2005)

Modulation of Cyp450, ALS1 and COX-2 signaling pathways induced by Candida albicans infection via novel antifungal agents
by: Rehab M Abdel Megeed, et al.
Published: (2018-03-01)

Oxylipin Profiles in Plasma of Patients with Wilson’s Disease
by: Nadezhda V. Azbukina, et al.
Published: (2020-05-01)

New formulation of ibuprofen on absorption-rate: A comparative bioavailability study in healthy volunteers
by: Yasaman Moghadamnia, et al.
Published: (2019-03-01)

Bedeutung der genetischen Polymorphismen in den Enzymen CYP2D6, CYP2C19 und CYP2C9 für Pharmakokinetik der trizyklischen Antidepressiva Doxepin und Trimipramin
by: Müller, Gunnar
Published: (2005)

Genotyping of the polymorphic drug metabolizing enzymes cytochrome P450 2D6 and 1A1, and N-acetyltransferase 2 in a Russian sample
by: Gaikovitch, Elena A.
Published: (2003)

Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
by: Shin D, et al.
Published: (2017-01-01)

Which COX-inhibitor to which patient; an analysis of contemporary evidence including pharmacology and medicinal chemistry
by: Persson, Jakob
Published: (2018)

Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
by: Geoffrey Mark Verrall, et al.
Published: (2020-09-01)

Investigations of the biocatalytic activity of human P450 2D6
by: Zhao, Jin, 1975-
Published: (2007)

Cox1 mutation abrogates need for Cox23 in cytochrome c oxidase biogenesis
by: Richard Dela Cruz, et al.
Published: (2016-06-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

Expression von EGFR, HER-2 und COX-2 beim Zervixkarzinom: Vergleich von Primärtumoren und Rezidiven
by: Fritzsche, Julia
Published: (2013)

Genetische Marker bei hausärztlichen Patienten mit oraler Antikoagulation
by: Hess, Stephan
Published: (2012)

Évaluation de la génotoxicité des contaminants environnementaux, production de lignées bio-senseurs et mesure de l'activité enzymatique du cytochrome P450 2E1 dans les cellules d'hépatome humain HepaRG
by: Quesnot, Nicolas
Published: (2015)

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
by: Serena Nembri, et al.
Published: (2016-06-01)

CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-03-01)

Ibuprofen, un medicament utilizat în durere, inflamaţie şi febră
by: Simona Negreş
Published: (2019-12-01)

The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
by: Maria eJohansson, et al.
Published: (2014-03-01)

Upregulation of COX4-2 via HIF-1α in Mitochondrial COX4-1 Deficiency
by: Liza Douiev, et al.
Published: (2021-02-01)

COX-2 as a potential biomarker and therapeutic target in melanoma
by: Diana Valentina Tudor, et al.
Published: (2020-02-01)

ORGANIZATION AND EVOLUTION OF THE CYP2A-T GENE SUBFAMILY CLUSTER IN RODENTS, AND A COMPARISON TO THE SYNTENIC HUMAN CLUSTER
by: Wang, Haoyi
Published: (2003)

Evolution of cytochrome c oxidase subunit 4 in relation to hypoxia
by: Kocha, Katrinka Maria
Published: (2012)

Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation
by: Qingbiao Huang, et al.
Published: (2018-05-01)

Utilization Pattern of NSAIDs and Gastroprotective Agents: A Prospective Analysis in Patients with Musculoskeletal Pain in A Tertiary Care Hospital
by: Resmi Douglas, et al.
Published: (2016-07-01)

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
by: Silvado CE, et al.
Published: (2018-03-01)

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial
by: Nicholas L. Syn, et al.
Published: (2018-07-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

Crystal Structure of CYP2B6 in Complex with an Efavirenz Analog
by: Manish B. Shah, et al.
Published: (2018-03-01)

Analysis of the role of Cox20 during the early steps of Cox2 biogenesis
by: Lorenzi, Isotta
Published: (2016)

NSAIDs and heart failure: A dangerous relationship
by: Raffaele Rotunno, et al.
Published: (2018-06-01)

The Role of Prostaglandins in Different Types of Cancer
by: Álvaro Jara-Gutiérrez, et al.
Published: (2021-06-01)

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer
by: Fei-fei Zhou, et al.
Published: (2018-01-01)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
by: Ron H. N. van Schaik, et al.
Published: (2020-09-01)

Étude biophysique du cytochrome P4503A4 humain
by: Plante, Mélanie
Published: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gpn448kscomfrknfmu83c6gjk2